Literature DB >> 8785169

Interleukin-6 (IL-6) in patients with Behçet's disease.

Y Yamakawa1, Y Sugita, T Nagatani, S Takahashi, T Yamakawa, S Tanaka, S Nakamura, S Ohno, H Sekihara, K Okuda, H Nakajima.   

Abstract

We have examined the levels of interleukin-6 (IL-6) in plasma and supernatants of peripheral blood mononuclear cells (PBMC) from patients with Behçet's disease and healthy controls using a sensitive enzyme-linked immunosorbent assay (ELISA). Plasma IL-6 level was not detected in any subjects. The IL-6 concentrations in culture supernatants of patients with active Behçet's disease were significantly high compared with patients with inactive disease and healthy controls. Moreover, we investigated IL-6 gene expression in cultured PBMC from patients with Behçet's disease. IL-6 gene expression was enhanced in active patients compared with inactive patients. These results show that IL-6 may play a role in the pathogenesis of Behçet's disease.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8785169     DOI: 10.1016/0923-1811(95)00439-4

Source DB:  PubMed          Journal:  J Dermatol Sci        ISSN: 0923-1811            Impact factor:   4.563


  12 in total

Review 1.  Interleukin 6 and cognitive dysfunction.

Authors:  Isabel Trapero; Omar Cauli
Journal:  Metab Brain Dis       Date:  2014-04-30       Impact factor: 3.584

2.  Plasma and whole-blood chemokine levels in patients with Behcet's disease.

Authors:  Toshikatsu Kaburaki; Yujiro Fujino; Hidetoshi Kawashima; Guillermo Merino; Jiro Numaga; Jun Chen; Kouji Matsushima
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-04-23       Impact factor: 3.117

3.  Genetic Polymorphisms in Transforming Growth Factor-β, Interferon-γ and Interleukin-6 Genes and Susceptibility to Behcet's Disease in Saudi Population.

Authors:  Fahdah Al Okaily; Seham Alrashidi; Mohammad Mustafa; Faris Bander Alrashdan
Journal:  Pharmgenomics Pers Med       Date:  2020-07-31

4.  MicroRNA155 Expression in Different Phenotypes and Genotypes of Behçet's Disease in a Sample of Egyptian Patients.

Authors:  Sally S Hassouna; Manal Y Tayel; Ashraf I Alzawawy; Dalal M Elkaffash; Ahmed M Abdel Hadi; Eman H Elsayed; Rowayda M Amin; Eman Tayae; Alya Elkayal; Asmaa Nasr
Journal:  Mediterr J Rheumatol       Date:  2020-09-30

5.  Cytokine Signatures in Mucocutaneous and Ocular Behçet's Disease.

Authors:  Giuseppe Lopalco; Orso Maria Lucherini; Antonio Lopalco; Vincenzo Venerito; Claudia Fabiani; Bruno Frediani; Mauro Galeazzi; Giovanni Lapadula; Luca Cantarini; Florenzo Iannone
Journal:  Front Immunol       Date:  2017-02-27       Impact factor: 7.561

Review 6.  HSV-Induced Systemic Inflammation as an Animal Model for Behçet's Disease and Therapeutic Applications.

Authors:  S M Shamsul Islam; Seonghyang Sohn
Journal:  Viruses       Date:  2018-09-19       Impact factor: 5.048

7.  MicroRNA-181b regulates endotoxin tolerance by targeting IL-6 in macrophage RAW264.7 cells.

Authors:  Wenjun Zhang; Xiaojun Shen; Luyang Xie; Maoping Chu; Yanmei Ma
Journal:  J Inflamm (Lond)       Date:  2015-03-02       Impact factor: 4.981

Review 8.  Diagnosis and management of Neuro-Behçet's disease: international consensus recommendations.

Authors:  Seema Kalra; Alan Silman; Gulsen Akman-Demir; Saeed Bohlega; Afshin Borhani-Haghighi; Cris S Constantinescu; Habib Houman; Alfred Mahr; Carlos Salvarani; Petros P Sfikakis; Aksel Siva; Adnan Al-Araji
Journal:  J Neurol       Date:  2013-12-24       Impact factor: 4.849

9.  Pharmacological Inactivation of Src Family Kinases Inhibits LPS-Induced TNF-α Production in PBMC of Patients with Behçet's Disease.

Authors:  Sevgi Irtegun; Gulsum Pektanc; Zeynep M Akkurt; Mehtap Bozkurt; Fatih M Turkcu; Sevgi Kalkanli-Tas
Journal:  Mediators Inflamm       Date:  2016-06-30       Impact factor: 4.711

10.  Putative Role of Serum Amyloid-A and Proinflammatory Cytokines as Biomarkers for Behcet's Disease.

Authors:  Giuseppe Lopalco; Orso Maria Lucherini; Antonio Vitale; Rosaria Talarico; Antonio Lopalco; Mauro Galeazzi; Giovanni Lapadula; Luca Cantarini; Florenzo Iannone
Journal:  Medicine (Baltimore)       Date:  2015-10       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.